RxSight, Inc.RXSTNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.3%
5Y CAGR+49.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+24.3%/yr
Annual compound
5Y CAGR
+49.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
7.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$112.65M+11.1%
2024$101.43M+35.6%
2023$74.80M+27.5%
2022$58.66M+78.8%
2021$32.80M+116.2%
2020$15.18M-0.2%
2019$15.20M-